학술논문
Isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) in front-line treatment of high-risk multiple myeloma: interim analysis of the GMMG-CONCEPT trial
Document Type
Article
Author
Source
In: Leukemia . (Leukemia, March 2022, 36(3):885-888)
Subject
Language
English
ISSN
14765551
08876924
08876924